Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693.
Jeon H, Wang S, Song J, Gill H, Cheng H. Update 2025: management of Non–Small-Cell lung cancer. Lung. 2025;203(1):53.
Article CAS PubMed PubMed Central Google Scholar
Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018;281(1):57–61.
Article CAS PubMed PubMed Central Google Scholar
Baker KJ, Houston A, Brint E. IL-1 family members in Cancer; two sides to every story. Front Immunol. 2019;10:1197.
Article CAS PubMed PubMed Central Google Scholar
Galozzi P, Bindoli S, Doria A, Sfriso P. The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities. Autoimmun Rev. 2021;20(4):102785.
Article CAS PubMed Google Scholar
Chiu JW, Binte Hanafi Z, Chew LC, Mei Y, Liu H. IL-1α Processing, signaling and its role in cancer progression. Cells [Internet]. 2021;10(1):92.
Article CAS PubMed PubMed Central Google Scholar
Gelfo V, Romaniello D, Mazzeschi M, Sgarzi M, Grilli G, Morselli A, et al. Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies. Int J Mol Sci. 2020;21(17):6009.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Gao Y, Lin T. Expression of interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) in non-small cell lung cancer and its relationship with the occurrence and prognosis of cancer pain. Annals Palliat Med. 2021;10(12):12759–66.
Peng TJ, Wu YC, Tang SJ, Sun GH, Sun KH. TGFβ1 induces CXCL1 to promote stemness features in lung cancer. Experimental Biology Med (Maywood NJ). 2023;248(23):2249–61.
Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, et al. Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res. 1996;16(1):53–60.
Zhang J, Luo J, Ni J, Tang L, Zhang HP, Zhang L, et al. MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells. Eur J Histochemistry: EJH. 2014;58(1):2262.
Malik A, Kanneganti TD. Function and regulation of IL-1α in inflammatory diseases and cancer. Immunol Rev. 2018;281(1):124–37.
Article CAS PubMed PubMed Central Google Scholar
Cheng KJ, Mejia Mohammed EH, Khong TL, Mohd Zain S, Thavagnanam S, Ibrahim ZA. IL-1α and colorectal cancer pathogenesis: enthralling candidate for anti-cancer therapy. Crit Rev Oncol/Hematol. 2021;163:103398.
Kundu S, Sengupta S, Bhattacharyya A. EGFR upregulates inflammatory and proliferative responses in human lung adenocarcinoma cell line (A549), induced by lower dose of cadmium chloride. Inhalation Toxicol. 2011;23(6):339–48.
Takahashi K, Ohta T. Membrane translocation of transient receptor potential Ankyrin 1 induced by inflammatory cytokines in lung cancer cells. Biochem Biophys Res Commun. 2017;490(3):587–93.
Article CAS PubMed Google Scholar
Vázquez-Gómez G, Karasová M, Tylichová Z, Kabátková M, Hampl A, Matthews J, et al. Aryl hydrocarbon receptor (AhR) limits the inflammatory responses in human lung adenocarcinoma A549 cells via interference with NF-κB. Signaling. 2022;11(4):707.
Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JEJJBC. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-κB and MAPKs*. J Biol Chem. 2004;279:13677–88.
Article CAS PubMed Google Scholar
Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J-i, Cao Z, Matsumoto KJN. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999;398:252–6.
Article CAS PubMed Google Scholar
Yamazaki K, Gohda J, Kanayama A, Miyamoto Y, Sakurai H, Yamamoto M, et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci Signal. 2009;2:ra66–66.
Liao H-Y, Da C-m, Liao B, Zhang H. -hJCb. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. 2021.
Korbecki J, Bosiacki M, Szatkowska I, Kupnicka P, Chlubek D, Baranowska-Bosiacka I. The clinical significance and involvement in molecular cancer processes of chemokine CXCL1 in selected tumors. Int J Mol Sci. 2024;25(8):4365.
Article CAS PubMed Google Scholar
Asokan, S., & Bandapalli, O. R, CXCL8 signaling in the tumor microenvironment. Tumor Microenvironment: The Role of Chemokines–Part B, 2021;1302:25–39.
Cheng KJ, Mohamed EHM, Syafruddin SE, Ibrahim ZA. Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis. J Cell Communication Signal. 2023;17(1):189–208.
Melisi D, Niu J, Chang Z, Xia Q, Peng B, Ishiyama S, et al. Secreted Interleukin-1α induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear Factor-κB. Molecular Cancer Res. 2009;7:624–33.
Article CAS PubMed PubMed Central Google Scholar
Nozaki S, Sledge GW Jr., Nakshatri H. Cancer cell-derived Interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun. 2000;275(1):60–2.
Article CAS PubMed Google Scholar
Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, et al. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Research: Official J Am Association Cancer Res. 2001;7(6):1812–20.
Yoshinaga K, Mimori K, Inoue H, Kamohara Y, Yamashita K, Tanaka F, et al. Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line. Int J Oncol. 2008;33 3:453–9.
Yuan G, Qian L, Song L, Shi M, Li D, Yu M, et al. Heregulin-β promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells. Mol Cell Biochem. 2008;318:73–9.
Comments (0)